The MAGIC Study and the Gastrointestinal Effects of Low-Dose Aspirin

[1]  Á. Lanas,et al.  Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  K. Sugano,et al.  Prospective Cohort Study of Gastrointestinal Complications and Vascular Diseases in Patients Taking Aspirin: Rationale and Design of the MAGIC Study , 2011, Cardiovascular Drugs and Therapy.

[3]  M. O’Donnell,et al.  Effect of aspirin on mortality in the primary prevention of cardiovascular disease. , 2011, The American journal of medicine.

[4]  J. Berger,et al.  Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. , 2011, American heart journal.

[5]  Andrew T Chan,et al.  Long-term use of aspirin and the risk of gastrointestinal bleeding. , 2011, The American journal of medicine.

[6]  A. Nakajima,et al.  Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan. , 2011, Hepato-gastroenterology.

[7]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[8]  David Ames,et al.  Feasibility of conducting a primary prevention trial of low‐dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study , 2008, The Medical journal of Australia.

[9]  Gianni Tognoni,et al.  Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.

[10]  Colin Baigent,et al.  Low-dose aspirin for the prevention of atherothrombosis. , 2005, The New England journal of medicine.

[11]  J. Slattery,et al.  Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial. , 1995, Gut.

[12]  J. McNeil,et al.  Adverse effects of low‐dose aspirin in a healthy elderly population , 1993, Clinical pharmacology and therapeutics.